Still the dominant route of administration for prescription drugs, oral drug delivery is evolving as newly discovered classes of therapeutically active compounds challenge the capabilities of traditional pills and capsules. A recent survey finds that developers of oral formulations are increasingly seeking new methods and technologies for delivering these new APIs in ways that achieve optimal pharmaceutical kinetics while insuring therapeutic bioavailability.
